132 related articles for article (PubMed ID: 156026)
21. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
[TBL] [Abstract][Full Text] [Related]
22. Remission-inducing drugs in rheumatoid arthritis.
Anastassiades TP
Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
[TBL] [Abstract][Full Text] [Related]
23. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.
Halla JT; Hardin JG; Linn JE
Arthritis Rheum; 1977; 20(6):1188-91. PubMed ID: 409414
[TBL] [Abstract][Full Text] [Related]
24. Liver dysfunction associated with gold therapy for rheumatoid arthritis.
Edelman J; Donnelly R; Graham DN; Percy JS
J Rheumatol; 1983 Jun; 10(3):510-1. PubMed ID: 6411922
[TBL] [Abstract][Full Text] [Related]
25. Gold reactions are not more common in Sjögren's syndrome.
Gordon MH; Tiger LH; Ehrlich GE
Ann Intern Med; 1975 Jan; 82(1):47-9. PubMed ID: 140617
[No Abstract] [Full Text] [Related]
26. Association of IgE antibodies to sodium aurothiomalate and adverse reactions to chrysotherapy for rheumatoid arthritis.
Bretza J; Wells I; Novey HS
Am J Med; 1983 Jun; 74(6):945-50. PubMed ID: 6407306
[TBL] [Abstract][Full Text] [Related]
27. Chrysotherapy and thrombocytopenia.
Madhok R; Pullar T; Capell HA; Dawood F; Sturrock RD; Dick HM
Ann Rheum Dis; 1985 Sep; 44(9):589-91. PubMed ID: 3929704
[TBL] [Abstract][Full Text] [Related]
28. HLA DR antigens and gold toxicity.
Gran JT; Husby G; Thorsby E
Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993
[TBL] [Abstract][Full Text] [Related]
29. Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. A prospective investigation.
de Bosset PL; Biter T
Schweiz Med Wochenschr; 1973 Aug; 103(33):1153-8. PubMed ID: 4201618
[No Abstract] [Full Text] [Related]
30. Acute renal failure due to gold.
Robbins G; McIllmurray MB
Postgrad Med J; 1980 May; 56(655):366-7. PubMed ID: 6777766
[TBL] [Abstract][Full Text] [Related]
31. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
32. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)].
Slobodina GA
Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846
[TBL] [Abstract][Full Text] [Related]
33. [A preliminary observation of chrysotherapy for rheumatoid arthritis].
Zhang NZ
Zhonghua Nei Ke Za Zhi; 1983 Mar; 22(3):149-51. PubMed ID: 6409538
[No Abstract] [Full Text] [Related]
34. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects].
Bene E; Megyeri A; Györi J
Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525
[TBL] [Abstract][Full Text] [Related]
35. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
Lawrence JS
Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
[TBL] [Abstract][Full Text] [Related]
36. Gold therapy in rheumatoid arthritis.
Majoos FL; Klemp P; Meyers OL; Briggs B
S Afr Med J; 1981 Jun; 59(27):971-4. PubMed ID: 6787722
[TBL] [Abstract][Full Text] [Related]
37. Serum gold. II. Levels in rheumatoid arthritis.
Rubinstein HM; Dietz AA
Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
[No Abstract] [Full Text] [Related]
38. Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study.
Wong CS; Champion G; Smith MD; Soden M; Wetherall M; Geddes RA; Hill WR; Ahern MJ; Roberts-Thomson PJ
Ann Rheum Dis; 1990 Jun; 49(6):370-2. PubMed ID: 2116773
[TBL] [Abstract][Full Text] [Related]
39. Chrysotherapy. A prospective study.
Rothermich NO; Philips VK; Bergen W; Thomas MH
Arthritis Rheum; 1976; 19(6):1321-7. PubMed ID: 826257
[TBL] [Abstract][Full Text] [Related]
40. Chrysotherapy-induced aplastic anemia: a case report.
Shearer CA; Parker WA
Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
